Additional Stroke Risk Factors Beyond the CHA₂DS₂-VA Score in Non-Valvular Atrial Fibrillation: An Interdisciplinary...

Area of Science:

• Cardiology
• Nephrology
• Endocrinology

Background:

• Optimal management of non-valvular atrial fibrillation (NVAF) involves controlling comorbidities and risk factors to prevent stroke.
• The CHA₂DS₂-VA score is a key tool for stroke risk assessment in NVAF patients.
• However, the score may not capture all relevant risk factors, necessitating further investigation.

Purpose of the Study:

• To review the latest literature on stroke risk factors in NVAF not included in the CHA₂DS₂-VA score.
• To analyze the clinical impact of these additional factors in NVAF patients with a CHA₂DS₂-VA score of 1.
• To refine daily clinical practice through interdisciplinary insights.

Main Methods:

• An interdisciplinary panel including cardiologists, an endocrinologist, and a nephrologist was convened.
• The panel discussed twenty open-ended questions regarding stroke risk stratification in NVAF patients with a CHA₂DS₂-VA score of 1.
• Evidence-based recommendations were formulated based on literature review and expert discussion.

Main Results:

• The CHA₂DS₂-VA score demonstrates limitations in accurately stratifying stroke risk for a significant number of NVAF patients with a score of 1.
• Integrating clinical, laboratory, and imaging predictors with the CHA₂DS₂-VA score can enhance stroke risk prediction.
• This refined approach aids in optimizing anticoagulation decisions for NVAF patients with a CHA₂DS₂-VA score of 1.

Conclusions:

• Additional risk factors beyond the CHA₂DS₂-VA score are crucial for comprehensive stroke risk assessment in NVAF.
• An interdisciplinary approach can identify individualized patient characteristics for better stroke prevention.
• Personalized management strategies focusing on early multidisciplinary prevention can improve long-term cardiovascular outcomes in NVAF patients.